Brainstorm Cell Therapeuticss Shares Halted on FDA Refusal for ALS Application
Brainstorm Cell Therapeutics's Shares Halted on FDA Refusal for ALS Application...…
0,205€
3,02%
Echtzeit-Aktienkurs Brainstorm Cell Therapeutics
Bid:
Ask:
Nachrichten zur Brainstorm Cell Therapeutics Aktie
BrainStorm Cell Therapeutics to Announce Third Quarter Results and Provide a Corporate Update
NEW YORK, Nov. 7, 2022 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell…
A Look At Some Of The Companies Innovating In the Cutting-Edge Regenerative Medicine Field
Biotechnology companies have broken many medical barriers in the past 40 years, harnessing the technological revolution to bring innovative solutions…
Form 8-K BRAINSTORM CELL THERAPEU For: Oct 07
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…